{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:18:44Z","timestamp":1789611524752,"version":"build-2803163510"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,12]]},"DOI":"10.18632\/oncotarget.7987","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T12:41:13Z","timestamp":1457440873000},"page":"20561-20573","source":"Crossref","is-referenced-by-count":18,"title":["RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia"],"prefix":"10.18632","volume":"7","author":[{"given":"Chunming","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"},{"name":"Insititute of Chinese Integrative Medicine, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxiao","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical College of Jinan University, Guangzhou 510632, China"},{"name":"Insititute of Chinese Integrative Medicine, Medical College of Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","article-title":"BCR-Tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in Chronic Myelogenous Leukemia","volume":"67","author":"Bhatia","year":"2007","journal-title":"Cancer Res"},{"key":"2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Sawyers","year":"2001","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Horowitz","year":"2006","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"Druker","year":"2011","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/10428194.2010.546920","article-title":"Mechanisms of resistance to BCR -ABL kinase inhibitors","volume":"52","author":"Melo","year":"2011","journal-title":"Leukemia Lymphoma"},{"key":"7","first-page":"585","article-title":"BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML","volume":"39","author":"von Eggeling","year":"2011","journal-title":"Int J Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"252ra121","DOI":"10.1126\/scitranslmed.3009073","article-title":"A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia","volume":"6","author":"Li","year":"2014","journal-title":"Sci Transl Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"Pawson","year":"1994","journal-title":"EMBO J"},{"key":"10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-1-5","article-title":"Effect of Ras inhibition in hematopoiesis and BCR\/ABL leukemogenesis","volume":"1","author":"Ren","year":"2008","journal-title":"J Hematol Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11684-013-0304-0","article-title":"The role of RAS effectors in BCR\/ABL induced chronic myelogenous leukemia","volume":"7","author":"Ren","year":"2013","journal-title":"Front Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/leu.2008.71","article-title":"Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis","volume":"22","author":"Williams","year":"2008","journal-title":"Leukemia"},{"key":"13","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1038\/onc.2009.260","article-title":"p210 (Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells","volume":"28","author":"Chang","year":"2009","journal-title":"Oncogene"},{"key":"14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-11-16","article-title":"RhoA: a therapeutic target for chronic myeloid leukemia","volume":"11","author":"Naik","year":"2012","journal-title":"Mol Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc2296","article-title":"Ral GTPases and cancer: Linchpin support of the tumorigenic platform","volume":"8","author":"White","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccr.2005.04.030","article-title":"Activation of RalA is critical for Ras-induced tumorigenesis of human cells","volume":"7","author":"Counter","year":"2005","journal-title":"Cancer Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature13713","article-title":"Discovery and characterization of small molecules that target the GTPase Ral","volume":"515","author":"Ahmed","year":"2014","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"e32834","DOI":"10.1371\/journal.pone.0032834","article-title":"miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.cellsig.2012.01.016","article-title":"Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells","volume":"24","author":"Fei","year":"2012","journal-title":"Cell Signal"},{"key":"20","doi-asserted-by":"crossref","first-page":"e3592","DOI":"10.1371\/journal.pone.0003592","article-title":"Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"e59532","DOI":"10.1371\/journal.pone.0059532","article-title":"Prognostic role of microRNA-181a\/b in hematological malignancies: a meta-analysis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"Agirre","year":"2009","journal-title":"Mol Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1755-8166-6-27","article-title":"Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia","volume":"6","author":"Knuutila","year":"2013","journal-title":"Mol Cytogenet"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:04:01Z","timestamp":1589223841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":23,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4,12]]}},"alternative-id":["7987","26967392"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7987","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}